Atopalm Hemorrhoidal Pain Relieving
NDC Package 51141-0220-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atopalm Hemorrhoidal Pain Relieving is do not use if foil seal under cap is broken or missing.Adults ■ when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Marketed by Neopharm Usa, this product is identified by NDC 51141-0220 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
51141-0220-1
Package Description
1 TUBE in 1 CARTON / 28.3 g in 1 TUBE
Product Code
11-Digit Billing Format
51141022001
RxNorm Crosswalk
  • RxCUI: 1293649 - glycerin 14.4 % / phenylephrine HCl 0.25 % / pramoxine HCl 1 % / white petrolatum 15 % Rectal Cream
  • RxCUI: 1293649 - glycerin 144 MG/ML / petrolatum 150 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream
  • RxCUI: 1293649 - glycerin 14.4 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 15 % Rectal Cream

Clinical Specifications

Proprietary Name
Atopalm Hemorrhoidal Pain Relieving
Dosage Form
-
Usage Information
Do not use if foil seal under cap is broken or missing.Adults ■ when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before applying cream ■ when first opening the tube, puncture foil seal with top end of cap ■ apply externally or in the lower portion of the anal canal only ■ apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement ■ for application in the lower anal canal, remove cover from the dispensing cap. Attach dispensing cap to tube, Lubricate dispensingcap well, then gently insert dispensing cap partway into the anus. ■ thoroughly cleanse dispensing cap after each use and replace cover.Children under 12 years of age■ ask a doctor.

Regulatory & Marketing

Labeler Name
Neopharm Usa
FDA Application #
part346
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
01-17-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51141-0220-1 identifies a specific commercial package of 1 tube in 1 carton / 28.3 g in 1 tube of Atopalm Hemorrhoidal Pain Relieving, labeled by Neopharm Usa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neopharm Usa on January 17, 2012. The current certification is valid through December 31, 2017.

How is this Neopharm Usa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51141022001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51141-0220-1
11-Digit CMS (5-4-2)
51141-0220-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.